About Contact Us Careers

Parenteral Nutrition Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 2775
Published Date: Oct 18, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the Parenteral Nutrition Landscape

Baxter International Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
SGD Pharma
Pfizer Inc.
B. Braun Melsungen AG
Fresenius Kabi
Grifols, S.A.
Sichuan Kelun Pharmaceutical Co. Ltd.
Otsuka Holdings Co. Ltd.
Claris Lifesciences Ltd.
Aculife

Browse Key Market Insights with Data Illustration:

Parenteral Nutrition Market Size & Share | Forecast Report 2036

In the News

September 2020 -. Baxter International Inc. made an announcement regarding the U.S. FDA approval of Clinimix and Clinimix E which consists of higher protein content mainly for patients who require parenteral nutrition.

Author Credits: Radhika Pawar

Report ID: 2775
Published Date: Oct 18, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of parenteral nutrition is assessed at USD 7.37 billion.

Parenteral Nutrition Market size was over USD 7.04 billion in 2023 and is projected to reach USD 14.83 billion by 2036, growing at around 5.9% CAGR during the forecast period i.e., between 2024-2036.

North America industry is poised to account for largest revenue share by 2036, due to increasing cases of chronic diseases such as cancer and diabetes in the region, growing approval of the U.S. FDA approved parenteral nutrition products coupled with increased R&D investment funding by leading companies.

The major players in the market are Baxter International Inc., SGD Pharma, Pfizer Inc., B. Braun Melsungen AG, Fresenius Kabi, Grifols, S.A., Sichuan Kelun Pharmaceutical Co. Ltd., Otsuka Holdings Co. Ltd., Claris Lifesciences Ltd., Aculife, and others.

Inquiry Before Buying Request Free Sample